US Patent 7259136 Compositions and methods for treating peripheral vascular disease

Patent 7259136 was granted and assigned to Amylin Pharmaceuticals on August, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amylin Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7259136

Date of Patent

August 21, 2007

Patent Application Number

10091258

Date Filed

March 5, 2002

Patent Primary Examiner

‌

Jon Weber

Patent abstract

The present invention relates to methods of treating intermittent claudication comprising administering glucagon-like peptide-1 (GLP-1) molecules to subjects suffering therefrom.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7259136 Compositions and methods for treating peripheral vascular disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API